..
To provide technical expertise to produce the final report on the early implementation of the Tricycle protocol, critically review and revise the protocol.
WHO developed the Global Antimicrobial Resistance and Use Surveillance System (GLASS) to to enable integrated analysis of standardized, comparable and validated data on AMR and AMC/AMU to be shared with countries and inform strategies to tackle AMR locally, regionally and globally. GLASS aims to foster national surveillance systems and will gather AMR and AMC/AMU surveillance information provided by the national governmental bodies. Currently more than 130 countries, territories and areas are participating in GLASS. More information on GLASS is available at https://www.who.int/initiatives/glass.
As part of GLASS-One Health Module, a multisectoral integrated approach for AMR surveillance targeting the extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli has been developed, known as the “Tricycle protocol”, resulting in the publication in March 2021 of the protocol WHO integrated global surveillance on ESBL-producing E. coli using a “One Health” approach: implementation and opportunities. The Tricycle Protocol has been applied in several countries during its development phase, and since its publication other countries have expressed the interest to also implement this approach. These countries have valued the protocol as a tool to foster the One Health integrated surveillance approach. An internal report on the lessons learnt from the early implementation of Tricycle has been developed. To finalize the in-depth analysis to inform the revision and further development of this One Health surveillance approach and its application, technical contribution from the WHO AMR Surveillance Collaborating Centres Network, implementing partners and other stakeholders is required. This offers an opportunity for improving the methodology to understand better the relatedness of AMR across the different sectors through the application of molecular epidemiology and new genotypic analytical tools and alignment of the Tricycle protocol with the approaches to One health integrated surveillance currently being developed by the Quadripartite.
Essential:
Desirable:
Essential:
Desirable:
Essential:
Desirable:
Off site: Home-based.
The consultant is not expected to travel.
Band level B – USD 7,000 – 9,980 per month.
N/A
Six months. Part-time at 70%. Remuneration will be pro-rated accordingly.